Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 10

Results: 17

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1701, doi. 10.1007/s00262-009-0681-z

By:

Britten, Cedrik Michael;
Janetzki, Sylvia;
Ben-Porat, Leah;
Clay, Timothy M.;
Kalos, Michael;
Maecker, Holden;
Odunsi, Kunle;
Pride, Michael;
Old, Lloyd;
Hoos, Axel;
Romero, Pedro

Publication type:

Article

Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4<sup>+</sup> T cells in a subset of cultures.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1679, doi. 10.1007/s00262-009-0679-6

By:

Ingram, Wendy;
Kordasti, Shahram;
Chan, Lucas;
Barber, Linda D.;
Tye, Gee J.;
Hardwick, Nicola;
Mufti, Ghulam J.;
Farzaneh, Farzin

Publication type:

Article

Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1565, doi. 10.1007/s00262-009-0666-y

By:

Le, Hanh K.;
Graham, Laura;
Miller, Catriona H. T.;
Kmieciak, Maciej;
Manjili, Masoud H.;
Bear, Harry Douglas

Publication type:

Article

Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1647, doi. 10.1007/s00262-009-0673-z

By:

Wujiang Liu;
O'Donnell, Michael A.;
Xiaohong Chen;
Ruifa Han;
Yi Luo

Publication type:

Article

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1599, doi. 10.1007/s00262-009-0669-8

By:

Helgadottir, Hildur;
Andersson, Emilia;
Villabona, Lisa;
Kanter, Lena;
van der Zanden, Henk;
Haasnoot, Geert W.;
Seliger, Barbara;
Bergfeldt, Kjell;
Hansson, Johan;
Ragnarsson-Olding, Boel;
Kiessling, Rolf;
Masucci, Giuseppe Valentino

Publication type:

Article

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1669, doi. 10.1007/s00262-009-0678-7

By:

Delluc, Stéphanie;
Hachem, Patricia;
Rusakiewicz, Sylvie;
Gaston, Auguste;
Marchiol-Fournigault, Carmen;
Tourneur, Lea;
Babchia, Narjes;
Fradelizi, Didier;
Regnault, Armelle;
Le Quan Sang, Kim Hanh;
Chiocchia, Gilles;
Buzyn, Agnès

Publication type:

Article

Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1577, doi. 10.1007/s00262-009-0667-x

By:

Nagai, Taku;
Tanaka, Masashi;
Tsuneyoshi, Yasuhiro;
Baohui Xu;
Michie, Sara A.;
Hasui, Kazuhisa;
Hirano, Hirofumi;
Arita, Kazunori;
Matsuyama, Takami

Publication type:

Article

Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1657, doi. 10.1007/s00262-009-0674-y

By:

Elkord, Eyad;
Dangoor, Adam;
Burt, Deborah J.;
Southgate, Thomas D.;
Daayana, Sai;
Harrop, Richard;
Drijfhout, Jan W.;
Sherlock, David;
Hawkins, Robert E.;
Stern, Peter L.

Publication type:

Article

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1627, doi. 10.1007/s00262-009-0671-1

By:

Banissi, Claire;
Ghiringhelli, François;
Chen, Lin;
Carpentier, Antoine F.

Publication type:

Article

Cancer/testis antigens can be immunological targets in clonogenic CD133<sup>+</sup> melanoma cells.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1635, doi. 10.1007/s00262-009-0672-0

By:

Gedye, Craig;
Quirk, Juliet;
Browning, Judy;
Svobodová, Suzanne;
John, Thomas;
Sluka, Pavel;
Dunbar, P. Rod;
Corbeil, Denis;
Cebon, Jonathan;
Davis, Ian D.

Publication type:

Article

Anti-cancer activity and mechanistic features of a NK cell activating molecule.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1691, doi. 10.1007/s00262-009-0680-0

By:

Hyung-Ran Kim;
Kyoung-Ho Lee;
Su Jung Park;
So Young Kim;
Young Keun Yang;
Jinsung Tae;
Jongsun Kim

Publication type:

Article

Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1557, doi. 10.1007/s00262-009-0663-1

By:

Vogl, Thomas Josef;
Wissniowski, Thaddäus;
Naguib, Nagy N. N.;
Hammerstingl, Renate M.;
Mack, Martin G.;
Münch, Sabine;
Ocker, Matthias;
Strobel, Deike;
Hahn, Eckhart G.;
Hänsler, Johannes

Publication type:

Article

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1609, doi. 10.1007/s00262-009-0670-2

By:

Kyte, Jon Amund;
Trachsel, Sissel;
Risberg, Bente;
Straten, Per thor;
Lislerud, Kari;
Gaudernack, Gustav

Publication type:

Article

Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1587, doi. 10.1007/s00262-009-0668-9

By:

Jun Zhou;
Desheng Weng;
Fangjian Zhou;
Ke Pan;
Haifeng Song;
Qijing Wang;
Huan Wang;
Hui Wang;
Yongqiang Li;
Lixi Huang;
Huakun Zhang;
Wei Huang;
Jianchuan Xia

Publication type:

Article

A systematic review of humoral immune responses against tumor antigens.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1535, doi. 10.1007/s00262-009-0733-4

By:

Reuschenbach, Miriam;
Knebel Doeberitz, Magnus von;
Wentzensen, Nicolas

Publication type:

Article

Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1715, doi. 10.1007/s00262-009-0688-5

By:

O'Donnell, Robert T.;
Pearson, David;
McKnight, Hayes C.;
Ma, Ya Peng;
Tuscano, Joseph M.

Publication type:

Article

Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1545, doi. 10.1007/s00262-009-0662-2

By:

Abdel-Motal, Ussama M.;
Wigglesworth, Kim;
Galili, Uri

Publication type:

Article